204 related articles for article (PubMed ID: 16580598)
21. The role of the cytokines and cell-adhesion molecules on the immunopathology of acute appendicitis.
Hachim MY; Ahmed AH
Saudi Med J; 2006 Dec; 27(12):1815-21. PubMed ID: 17143355
[TBL] [Abstract][Full Text] [Related]
22. Cell-based assays in GPCR drug discovery.
Siehler S
Biotechnol J; 2008 Apr; 3(4):471-83. PubMed ID: 18383022
[TBL] [Abstract][Full Text] [Related]
23. Taming the PI3K team to hold inflammation and cancer at bay.
Hirsch E; Ciraolo E; Ghigo A; Costa C
Pharmacol Ther; 2008 May; 118(2):192-205. PubMed ID: 18420279
[TBL] [Abstract][Full Text] [Related]
24. Interrogating 7TM receptors: does texture in the question yield greater texture in the answer?
Kenakin T
J Recept Signal Transduct Res; 2009; 29(3-4):132-9. PubMed ID: 19580378
[TBL] [Abstract][Full Text] [Related]
25. Deorphanisation of G protein-coupled receptors: A tool to provide new insights in nervous system pathophysiology and new targets for psycho-active drugs.
Lecca D; Abbracchio MP
Neurochem Int; 2008 Feb; 52(3):339-51. PubMed ID: 17884255
[TBL] [Abstract][Full Text] [Related]
26. An apparent paradox: chemokine receptor agonists can be used for anti-inflammatory therapy.
Ali S; O'Boyle G; Mellor P; Kirby JA
Mol Immunol; 2007 Mar; 44(7):1477-82. PubMed ID: 17000001
[TBL] [Abstract][Full Text] [Related]
27. Cytokines regulating osteoclast formation and function.
Lee SK; Lorenzo J
Curr Opin Rheumatol; 2006 Jul; 18(4):411-8. PubMed ID: 16763463
[TBL] [Abstract][Full Text] [Related]
28. Signalling platforms that modulate the inflammatory response: new targets for drug development.
McCulloch CA; Downey GP; El-Gabalawy H
Nat Rev Drug Discov; 2006 Oct; 5(10):864-76. PubMed ID: 17016427
[TBL] [Abstract][Full Text] [Related]
29. New insights into GPCR function: implications for HTS.
Eglen RM; Reisine T
Methods Mol Biol; 2009; 552():1-13. PubMed ID: 19513638
[TBL] [Abstract][Full Text] [Related]
30. Embryonic implantation: cytokines, adhesion molecules, and immune cells in establishing an implantation environment.
van Mourik MS; Macklon NS; Heijnen CJ
J Leukoc Biol; 2009 Jan; 85(1):4-19. PubMed ID: 18784344
[TBL] [Abstract][Full Text] [Related]
31. Dimerization of chemokine receptors in living cells: key to receptor function and novel targets for therapy.
Wang J; Norcross M
Drug Discov Today; 2008 Jul; 13(13-14):625-32. PubMed ID: 18598920
[TBL] [Abstract][Full Text] [Related]
32. Role of cholesterol in the function and organization of G-protein coupled receptors.
Pucadyil TJ; Chattopadhyay A
Prog Lipid Res; 2006 Jul; 45(4):295-333. PubMed ID: 16616960
[TBL] [Abstract][Full Text] [Related]
33. Marine sponge metabolites for the control of inflammatory diseases.
Alcaraz MJ; Payá M
Curr Opin Investig Drugs; 2006 Nov; 7(11):974-9. PubMed ID: 17117584
[TBL] [Abstract][Full Text] [Related]
34. Review. Leukocyte and endothelial cell adhesion molecules in inflammation focusing on inflammatory heart disease.
Golias C; Tsoutsi E; Matziridis A; Makridis P; Batistatou A; Charalabopoulos K
In Vivo; 2007; 21(5):757-69. PubMed ID: 18019409
[TBL] [Abstract][Full Text] [Related]
35. A combined approach for the classification of G protein-coupled receptors and its application to detect GPCR splice variants.
Eo HS; Choi JP; Noh SJ; Hur CG; Kim W
Comput Biol Chem; 2007 Aug; 31(4):246-56. PubMed ID: 17631418
[TBL] [Abstract][Full Text] [Related]
36. [The immune system: new therapeutic targets].
Pasquali JL
Rev Neurol (Paris); 2002 Oct; 158(10 Pt 1):893-7. PubMed ID: 12407296
[TBL] [Abstract][Full Text] [Related]
37. G-protein-coupled receptor-focused drug discovery using a target class platform approach.
Heilker R; Wolff M; Tautermann CS; Bieler M
Drug Discov Today; 2009 Mar; 14(5-6):231-40. PubMed ID: 19121411
[TBL] [Abstract][Full Text] [Related]
38. Progress in the discovery and development of small-molecule modulators of G-protein-coupled receptor 40 (GPR40/FFA1/FFAR1): an emerging target for type 2 diabetes.
Bharate SB; Nemmani KV; Vishwakarma RA
Expert Opin Ther Pat; 2009 Feb; 19(2):237-64. PubMed ID: 19441920
[TBL] [Abstract][Full Text] [Related]
39. Blocking of adhesion molecules in vivo as anti-inflammatory therapy.
Ward PA; Mulligan MS
Ther Immunol; 1994 Jun; 1(3):165-71. PubMed ID: 7584492
[No Abstract] [Full Text] [Related]
40. Targeting phosphoinositide 3-kinase gamma to fight inflammation and more.
Barberis L; Hirsch E
Thromb Haemost; 2008 Feb; 99(2):279-85. PubMed ID: 18278175
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
